시장보고서

상품코드

1629167

바이오시밀러 인슐린 시장 : 종류별, 적응증별, 유통 채널별, 국가별, 지역별 - 산업 분석, 시장 규모 및 점유율, 예측(2024-2032년)

Biosimilar Insulin Market, By Type, By Indication, By Distribution Channel, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

발행일: 2024년 12월 | 리서치사:

AnalystView Market Insights | 페이지 정보: 영문 260 Pages | 배송안내 : 2-3일 (영업일 기준)

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

보고서 하이라이트

바이오시밀러 인슐린 시장 규모는 2023년 26억 9,087만 달러로 2024년부터 2032년까지 16.44%의 CAGR(연평균 성장률)로 확대될 전망입니다.

바이오시밀러 인슐린 시장 역학

전 세계 당뇨병 유병률 증가로 시장 수요 증가 촉진

당뇨병 유병률의 증가는 세계 바이오시밀러 인슐린 시장의 수요를 촉진하고 있습니다. 당뇨병 연구개발에 대한 투자가 증가하고 오리지널 인슐린의 특허가 만료됨에 따라 바이오시밀러 인슐린이 시장을 주도하고 있습니다. 전 세계적으로 5억 명 이상이 당뇨병을 앓고 있으며, 비용 효율적인 인슐린 제제에 대한 수요가 급증하고 있습니다. 그러나 규제상의 어려움과 임상에서의 제한적인 수용이 장기적인 보급에 걸림돌이 되고 있습니다. 반면, 오랜 역사를 가진 오리지널 인슐린 제제의 특허 만료는 혁신적인 신규 바이오시밀러 인슐린 제제에 대한 수요를 촉진하고 제조업체에 성장 기회를 제공할 것으로 예상됩니다.

바이오시밀러 인슐린 시장 : 주요 인사이트

당사의 연구 분석가들의 분석에 따르면, 세계 시장은 예측 기간(2024-2032년) 동안 약 16.44%의 CAGR로 매년 성장할 것으로 예상됩니다.

유형별 세분화에서, 속효성 인슐린은 2023년에 가장 큰 시장 점유율을 나타낼 것으로 예측되었습니다.

적응증별로는 제 2형 당뇨병이 2023년 주요 부문으로 부상했습니다.

지역별로는 북미가 2023년 매출 1위를 차지했습니다.

바이오시밀러 인슐린 시장 : 세분화 분석

바이오시밀러 인슐린 세계 시장은 유형, 적응증, 유통 채널, 지역에 따라 세분화됩니다.

시장은 종류에 따라 지속형 인슐린, 중간형 인슐린, 속효성 인슐린의 세 가지로 분류됩니다. 속효성 인슐린 분야가 시장을 독점하고 있습니다. 이 성장의 원동력은 식후 혈당 상승을 조절하는 효과와 당뇨병 환자들에게 매력적인 바이오시밀러의 비용 효율성입니다.

시장은 적응증에 따라 1형 당뇨병과 제2형 당뇨병의 두 가지 범주로 나뉘며, 제2형 당뇨병 부문이 시장을 지배하고 있으며, 예측 기간 동안 그 우위를 유지할 것으로 예상됩니다. 이는 전 세계적으로 제 2형 당뇨병의 유병률이 증가함에 따라 바이오시밀러 인슐린 시장의 매력도가 높아지고 있기 때문입니다.

바이오시밀러 인슐린 시장 : 지역별 분석

이 시장은 북미, 라틴아메리카, 유럽, 아시아태평양, 중동 및 아프리카에 널리 분포되어 있습니다. 이 지역은 비즈니스를 가져오는 국가에 따라 더 세분화됩니다.

바이오시밀러 인슐린 시장 : 경쟁 상황

비용 효율적인 당뇨병 치료제에 대한 수요 증가에 힘입어 제약사들은 환자들의 다양한 요구에 부응하기 위해 제품 포트폴리오를 확장하고 있습니다. 각 업체들은 신속한 승인을 위해 규제 당국에 효율적으로 대응하는 한편, 연구개발을 강화하기 위해 제휴 및 공동연구를 채택하고 있습니다. 현지 제약사와의 제휴를 통해 신흥 지역으로의 전략적 시장 진출이 가능해졌으며, 현지 시장 수요에 맞는 제품 개발 및 접근성 향상을 통해 경쟁력을 강화하고 있습니다.

소개
북미
- 개요
- 북미의 주요 제조업체
- 미국
- 캐나다
유럽
- 개요
- 유럽의 주요 제조업체
- 독일
- 이탈리아
- 영국
- 프랑스
- 러시아
- 네덜란드
- 스웨덴
- 폴란드
- 기타
아시아태평양(APAC)
- 개요
- 아시아태평양의 주요 제조업체
- 인도
- 중국
- 일본
- 한국
- 호주
- 태국
- 인도네시아
- 필리핀
- 기타
라틴아메리카
- 개요
- 라틴아메리카의 주요 제조업체
- 브라질
- 멕시코
- 아르헨티나
- 콜롬비아
- 기타
중동 및 아프리카
- 개요
- 중동 및 아프리카의 주요 제조업체
- 사우디아라비아
- 아랍에미리트
- 이스라엘
- 터키
- 알제리
- 이집트
- 기타

제11장 주요 벤더 분석 : 바이오시밀러 인슐린 업계

경쟁 대시보드
- 경쟁 벤치마크
- 경쟁 포지셔닝
기업 개요
- Eli Lilly and Company
- BIOTON SA
- Sanofi SA
- WOCKHARDT
- Biocon Ltd.
- Julphar
- Tonghua Dongbao
- Popular Pharmaceuticals Ltd.
- Polfa Tarchomin SA
- Advanced Chemical Industries Limited
- SEDICO Co.
- Denver Farma SA
- Aristopharma Ltd.
- Boehringer Ingelheim
- NOVO Nordisk A/S
- Merck &Co.
- Mylan NV
- Sandoz
- Fresenius Kabi
- Pfizer Inc.
- BGP Pharma
- Aspen
- Others

제12장 AnalystView의 전방위적 분석

ksm 25.02.12

REPORT HIGHLIGHT

Biosimilar insulin market size was valued at USD 2,690.87 Million in 2023, expanding at a CAGR of 16.44% from 2024 to 2032.

Biosimilar insulin is a type of insulin product that closely resembles an already approved "reference" insulin in terms of structure, safety, and effectiveness but is typically offered at a lower cost. Developed to treat diabetes, biosimilar insulins undergo rigorous testing to confirm their similarity to existing insulin types, ensuring comparable performance. These products provide diabetic patients with more affordable treatment options, expanding access to vital, life-sustaining insulin therapies globally.

Biosimilar Insulin Market- Market Dynamics

Increasing prevalence of diabetes worldwide to propel market demand

The increasing prevalence of diabetes is driving demand for the global biosimilar insulin market. As investments in diabetes R&D rise and original insulin patents expire, biosimilar insulin is gaining traction. With over 500 million people worldwide affected by diabetes, the need for cost-effective insulin options has soared. However, regulatory challenges and limited clinical acceptance pose barriers to wider adoption in the long term. On the contrary, patent expirations of long-established originator insulin products are expected to drive demand for innovative new biosimilar insulins, creating growth opportunities for manufacturers.

Biosimilar Insulin Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 16.44% over the forecast period (2024-2032)

Based on type segmentation, fast-acting insulin was predicted to show maximum market share in the year 2023

Based on indication segmentation, diabetes type 2 was the leading segment in 2023

On the basis of region, North America was the leading revenue generator in 2023

Biosimilar Insulin Market- Segmentation Analysis:

The Global Biosimilar Insulin Market is segmented on the basis of Type, Indication, Distribution Channel, and Region.

The market is divided into three categories based on type: long-acting insulin, intermediate-acting insulin, and fast-acting insulin. The fast-acting insulin sector dominates the market. This growth is driven by its effectiveness in managing postprandial glucose spikes and the cost-effectiveness of biosimilars, appealing to diabetic patients.

The market is divided into two categories based on indication: Diabetes Type 1 and Diabetes Type 2. The diabetes type 2 sector dominates the market and is likely to maintain its dominance during the forecast period. This is partly due to the rising global incidence of type 2 diabetes, which has made the biosimilar insulin market more appealing.

Biosimilar Insulin Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Biosimilar Insulin Market- Competitive Landscape:

Driven by rising demand for cost-effective diabetes treatments, manufacturers are expanding their product portfolios to address diverse patient needs. Companies are focusing on efficient regulatory navigation for faster approvals while adopting partnerships and collaborations to strengthen research, development. Collaborative agreements with local pharmaceutical firms enable strategic market entry in emerging regions, enhancing their competitive edge by tailoring products to regional market demands and improving accessibility.

Recent Developments:

In December 2023, USV and Biogenomics launched INSUQUICK, India's first biosimilar Insulin Aspart, to enhance diabetes care. Developed with 100% indigenous technology, it meets global quality standards through rigorous clinical testing.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL BIOSIMILAR INSULIN MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Eli Lilly and Company
BIOTON S.A.
Sanofi SA
WOCKHARDT
Biocon Ltd.
Julphar
Tonghua Dongbao
Popular Pharmaceuticals Ltd.
Polfa Tarchomin S.A
Advanced Chemical Industries Limited
SEDICO Co.
Denver Farma S.A
Aristopharma Ltd.
Boehringer Ingelheim
NOVO Nordisk A/S
Merck & Co.
Mylan N.V.
Sandoz
Fresenius Kabi
Pfizer Inc.
BGP Pharma
Aspen
Others

GLOBAL BIOSIMILAR INSULIN MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032

Long-acting Insulin
Intermediate-acting Insulin
Fast-acting Insulin

GLOBAL BIOSIMILAR INSULIN MARKET, BY INDICATION- MARKET ANALYSIS, 2019 - 2032

Diabetes Type 1
Diabetes Type 2

GLOBAL BIOSIMILAR INSULIN MARKET, BY DISTRIBUTION CHANNEL- MARKET ANALYSIS, 2019 - 2032

Retail Pharmacies
Hospital Pharmacies
Online Pharmacies
Drug Stores

GLOBAL BIOSIMILAR INSULIN MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

North America
The U.S.
Canada
Europe
Germany
France
Italy
Spain
United Kingdom
Russia
Netherlands
Sweden
Poland
Rest of Europe
Asia Pacific
India
China
South Korea
Japan
Australia
Thailand
Indonesia
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
United Arab Emirates
Israel
Turkey
Algeria
Egypt
Rest of MEA

1. Biosimilar Insulin Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
- 2.1.1. Biosimilar Insulin Market Snippet by Type
- 2.1.2. Biosimilar Insulin Market Snippet by Indication
- 2.1.3. Biosimilar Insulin Market Snippet by Distribution Channel
- 2.1.4. Biosimilar Insulin Market Snippet by Country
- 2.1.5. Biosimilar Insulin Market Snippet by Region
2.2. Competitive Insights

3. Biosimilar Insulin Key Market Trends

3.1. Biosimilar Insulin Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. Biosimilar Insulin Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. Biosimilar Insulin Market Opportunities
3.4. Biosimilar Insulin Market Future Trends

4. Biosimilar Insulin Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. Biosimilar Insulin Market: Impact of Escalating Geopolitical Tensions

5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts

6. Biosimilar Insulin Market Landscape

6.1. Biosimilar Insulin Market Share Analysis, 2023
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. Biosimilar Insulin Market - By Type

7.1. Overview
- 7.1.1. Segment Share Analysis, By Type, 2023 & 2032 (%)
- 7.1.2. Long-acting Insulin
- 7.1.3. Intermediate-acting Insulin
- 7.1.4. Fast-acting Insulin

8. Biosimilar Insulin Market - By Indication

8.1. Overview
- 8.1.1. Segment Share Analysis, By Indication, 2023 & 2032 (%)
- 8.1.2. Diabetes Type 1
- 8.1.3. Diabetes Type 2

9. Biosimilar Insulin Market - By Distribution Channel

9.1. Overview
- 9.1.1. Segment Share Analysis, By Distribution Channel, 2023 & 2032 (%)
- 9.1.2. Retail Pharmacies
- 9.1.3. Hospital Pharmacies
- 9.1.4. Online Pharmacies
- 9.1.5. Drug Stores

10. Biosimilar Insulin Market- By Geography

10.1. Introduction
- 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
10.2. North America
- 10.2.1. Overview
- 10.2.2. Biosimilar Insulin Key Manufacturers in North America
- 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.2.4. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.2.5. North America Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 10.2.6. North America Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 10.2.7. U.S.
  - 10.2.7.1. Overview
  - 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.2.7.3. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.2.7.4. U.S. Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.2.7.5. U.S. Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 10.2.8. Canada
  - 10.2.8.1. Overview
  - 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.2.8.3. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.2.8.4. Canada Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.2.8.5. Canada Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
10.3. Europe
- 10.3.1. Overview
- 10.3.2. Biosimilar Insulin Key Manufacturers in Europe
- 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.3.4. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.3.5. Europe Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 10.3.6. Europe Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 10.3.7. Germany
  - 10.3.7.1. Overview
  - 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.7.3. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.3.7.4. Germany Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.3.7.5. Germany Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 10.3.8. Italy
  - 10.3.8.1. Overview
  - 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.8.3. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.3.8.4. Italy Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.3.8.5. Italy Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 10.3.9. United Kingdom
  - 10.3.9.1. Overview
  - 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.9.3. United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.3.9.4. United Kingdom Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.3.9.5. United Kingdom Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 10.3.10. France
  - 10.3.10.1. Overview
  - 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.10.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.3.10.4. France Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.3.10.5. France Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 10.3.11. Russia
  - 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.11.2. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.3.11.3. Russia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.3.11.4. Russia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 10.3.12. Netherlands
  - 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.12.2. Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.3.12.3. Netherlands Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.3.12.4. Netherlands Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 10.3.13. Sweden
  - 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.13.2. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.3.13.3. Sweden Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.3.13.4. Sweden Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 10.3.14. Poland
  - 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.14.2. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.3.14.3. Poland Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.3.14.4. Poland Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 10.3.15. Rest of Europe
  - 10.3.15.1. Overview
  - 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.15.3. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.3.15.4. Rest of the Europe Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.3.15.5. Rest of the Europe Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
10.4. Asia Pacific (APAC)
- 10.4.1. Overview
- 10.4.2. Biosimilar Insulin Key Manufacturers in Asia Pacific
- 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.4.4. Asia Pacific Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.4.5. Asia Pacific Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 10.4.6. Asia Pacific Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 10.4.7. India
  - 10.4.7.1. Overview
  - 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.7.3. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.4.7.4. India Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.4.7.5. India Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 10.4.8. China
  - 10.4.8.1. Overview
  - 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.8.3. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.4.8.4. China Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.4.8.5. China Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 10.4.9. Japan
  - 10.4.9.1. Overview
  - 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.9.3. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.4.9.4. Japan Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.4.9.5. Japan Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 10.4.10. South Korea
  - 10.4.10.1. Overview
  - 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.10.3. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.4.10.4. South Korea Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.4.10.5. South Korea Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 10.4.11. Australia
  - 10.4.11.1. Overview
  - 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.11.3. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.4.11.4. Australia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.4.11.5. Australia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 10.4.12. Thailand
  - 10.4.12.1. Overview
  - 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.12.3. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.4.12.4. Thailand Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.4.12.5. Thailand Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 10.4.13. Indonesia
  - 10.4.13.1. Overview
  - 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.13.3. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.4.13.4. Indonesia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.4.13.5. Indonesia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 10.4.14. Philippines
  - 10.4.14.1. Overview
  - 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.14.3. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.4.14.4. Philippines Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.4.14.5. Philippines Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 10.4.15. Rest of APAC
  - 10.4.15.1. Overview
  - 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.15.3. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.4.15.4. Rest of APAC Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.4.15.5. Rest of APAC Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
10.5. Latin America
- 10.5.1. Overview
- 10.5.2. Biosimilar Insulin Key Manufacturers in Latin America
- 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.5.4. Latin America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.5.5. Latin America Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 10.5.6. Latin America Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 10.5.7. Brazil
  - 10.5.7.1. Overview
  - 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.7.3. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.5.7.4. Brazil Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.5.7.5. Brazil Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 10.5.8. Mexico
  - 10.5.8.1. Overview
  - 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.8.3. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.5.8.4. Mexico Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.5.8.5. Mexico Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 10.5.9. Argentina
  - 10.5.9.1. Overview
  - 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.9.3. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.5.9.4. Argentina Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.5.9.5. Argentina Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 10.5.10. Colombia
  - 10.5.10.1. Overview
  - 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.10.3. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.5.10.4. Colombia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.5.10.5. Colombia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 10.5.11. Rest of LATAM
  - 10.5.11.1. Overview
  - 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.11.3. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.5.11.4. Rest of LATAM Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.5.11.5. Rest of LATAM Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
10.6. Middle East and Africa
- 10.6.1. Overview
- 10.6.2. Biosimilar Insulin Key Manufacturers in Middle East and Africa
- 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.6.4. Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.6.5. Middle East and Africa Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 10.6.6. Middle East and Africa Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 10.6.7. Saudi Arabia
  - 10.6.7.1. Overview
  - 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.7.3. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.6.7.4. Saudi Arabia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.6.7.5. Saudi Arabia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 10.6.8. United Arab Emirates
  - 10.6.8.1. Overview
  - 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.8.3. United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.6.8.4. United Arab Emirates Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.6.8.5. United Arab Emirates Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 10.6.9. Israel
  - 10.6.9.1. Overview
  - 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.9.3. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.6.9.4. Israel Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.6.9.5. Israel Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 10.6.10. Turkey
  - 10.6.10.1. Overview
  - 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.10.3. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.6.10.4. Turkey Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.6.10.5. Turkey Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 10.6.11. Algeria
  - 10.6.11.1. Overview
  - 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.11.3. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.6.11.4. Algeria Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.6.11.5. Algeria Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 10.6.12. Egypt
  - 10.6.12.1. Overview
  - 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.12.3. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.6.12.4. Egypt Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.6.12.5. Egypt Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 10.6.13. Rest of MEA
  - 10.6.13.1. Overview
  - 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.13.3. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.6.13.4. Rest of MEA Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.6.13.5. Rest of MEA Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Biosimilar Insulin Industry

11.1. Competitive Dashboard
- 11.1.1. Competitive Benchmarking
- 11.1.2. Competitive Positioning
11.2. Company Profiles
- 11.2.1. Eli Lilly and Company
- 11.2.2. BIOTON S.A.
- 11.2.3. Sanofi SA
- 11.2.4. WOCKHARDT
- 11.2.5. Biocon Ltd.
- 11.2.6. Julphar
- 11.2.7. Tonghua Dongbao
- 11.2.8. Popular Pharmaceuticals Ltd.
- 11.2.9. Polfa Tarchomin S.A
- 11.2.10. Advanced Chemical Industries Limited
- 11.2.11. SEDICO Co.
- 11.2.12. Denver Farma S.A
- 11.2.13. Aristopharma Ltd.
- 11.2.14. Boehringer Ingelheim
- 11.2.15. NOVO Nordisk A/S
- 11.2.16. Merck & Co.
- 11.2.17. Mylan N.V.
- 11.2.18. Sandoz
- 11.2.19. Fresenius Kabi
- 11.2.20. Pfizer Inc.
- 11.2.21. BGP Pharma
- 11.2.22. Aspen
- 11.2.23. Others

12. 360 Degree Analyst View

13. Appendix

13.1. Research Methodology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us